HIV-1 infection of non-dividing cells: Evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import

EMBO Journal

Volumn 16, Issue 15, 1997, Pages 4531-4539

  Fouchier, Ron A M ^a   Meyer, Barbara E ^a   Simon, James H M ^b   Fischer, Utz ^a   Malim, Michael H ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Gag processing; HIV 1; Macrophages; Matrix protein; Nuclear import

Indexed keywords

GAG PROTEIN; MATRIX PROTEIN; PROTEINASE; VIRUS ENZYME; VIRUS NUCLEOPROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE DISRUPTION; GENE MUTATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; VIROGENESIS; VIRUS INFECTIVITY; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CELL NUCLEUS; FEMALE; GENE PRODUCTS, GAG; HELA CELLS; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; MUTAGENESIS, SITE-DIRECTED; OOCYTES; PROTEIN PRECURSORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRUS REPLICATION; XENOPUS LAEVIS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030747461     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/16.15.4531     Document Type: Article

References (61)

1. Balliet, J.W., Kolson, D.L., Eiger, G., Kim, F.M., McGann, K.A., Srinivasan, A. and Collman, R. (1994) Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate. Virology, 200, 623-631.
2. Bukrinskaya, A.G., Ghorpade, A., Heinzinger, N.K., Smithgall, T.E., Lewis, R.E. and Stevenson, M. (1996) Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl Acad. Sci. USA, 93, 367-371.
3. Bukrinsky, M.I., Sharova, N., Dempsey, M.R. Stanwick, T.L., Bukrinskaya, A.G., Haggerty, S. and Stevenson, M. (1992) Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc. Natl Acad. Sci. USA, 89, 6580-6584.
4. Bukrinsky, M.I. et al. (1993a) A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature, 365, 666-669.
5. Bukrinsky, M.I., Sharova, N., McDonald, T.L., Pushkarskaya, T., Tarpley, W.G. and Stevenson, M. (1993b) Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl Acad. Sci. USA, 90, 6125-6129.
6. Choe, H. et al. (1996) The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell, 85, 1135-1148.
7. Collman, R., Hassan, N.F., Walker, R., Godfrey, B., Cutilli, J., Hastings, J.C., Friedman, H., Douglas, S.D. and Nathanson, N. (1989) Infection of monocyte-derived macrophages with human immunodeficiency virus type 1 (HIV-1). J. Exp. Med., 170, 1149-1163.
8. Connor, R.I. and Ho, D.D. (1994) Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol., 68, 4400-4408.
9. Connor, R.I., Chen, B.K., Choe, S. and Landau, N.R. (1995) Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology, 206, 935-944.
10. Cornelissen, M. et al. (1995) Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J. Virol., 69, 1810-1818.
11. Davis, L.I. (1995) The nuclear pore complex. Annu. Rev. Biochem., 64, 865-896.
12. Dingwall, C. (1996) Transporting nuclear proteins. Nature, 384, 210-211.
13. Dingwall, C. and Laskey, R.A. (1991) Nuclear targeting sequences - a consensus? Trends Biochem. Sci., 16, 478-481.
14. Dworetzky, S.I. and Feldherr, C.M.(1988) Translocation of RNA-coated gold particles through the nuclear pores of oocytes. J. Cell Biol., 106, 575-584.
15. Evan, G., Lewis, G., Ramsay, G. and Bishop, J.M. (1985) Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol., 5, 3610-3616.
16. Fantozzi, D.A., Harootunian, A.T., Wen, W., Taylor, S.S., Feramisco, J.R., Tsien, R.Y. and Meinkoth, J.L. (1994) Thermostable inhibitor of cAMP-dependent protein kinase enhances the rate of export of the kinase catalytic subunit from the nucleus. J. Biol. Chem., 269, 2676-2686.
17. Farnet, C.M. and Haseltine, W.A. (1990) Integration of human immunodeficiency virus type 1 DNA in vitro. Proc. Natl Acad. Sci. USA, 87, 4164-4168.
18. Feldherr, C.M. Kallenbach, E. and Schultz, N. (1984) Movement of a karyophilic protein through the nuclear pores of oocytes. J. Cell Biol., 99, 2216-2222.
19. Fischer, U., Sumpter, V. Sekine, M., Satoh, T. and Lührmann, R. (1993) Nucleo-cytoplasmic transport of U snRNPs: definition of a nuclear location signal in the Sm core domain that binds a transport receptor independently of the m3G cap. EMBO J., 12, 573-583.
20. Fischer, U., Huber, J., Boelens, W.C., Mattaj, I.W. and Luhrmann, R. (1995) The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell, 82, 475-483.
21. SM. EMBO J., 15, 6155-6165.
22. Freed, E.O., Englund, G. and Martin, M.A. (1995) Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J. Virol., 69, 3949-3954.
23. Gallay, P., Swingler, S., Aiken, C. and Trono, D. (1995a) HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell, 80, 379-388.
24. Gallay, P., Swingler, S., Song, J., Bushman, F. and Trono, D. (1995b) HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell, 83, 569-576.
25. Garcia-Bustos, J., Heitman, J. and Hall, M.N. (1991) Nuclear protein localization. Biochim. Biophys. Acta, 1071, 83-101.
26. Gartner, S., Markovits, P. Markotitz, D.M., Kaplan, M.H., Gallo, R.C. and Popovic, M. (1986) The role of mononuclear phagocytes in HTLV-III/LAV infection. Science, 233, 215-219.
27. Görlich, D. and Mattaj, I.W. (1996) Nucleocytoplasmic transport. Science, 271, 1513-1518.
28. Göttlinger, H.G., Sodroski, J.G. and Haseltine, W.A. (1989) Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA, 86, 5781-5785.
29. Heinzinger, N.K. et al. (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl Acad. Sci. USA, 91, 7311-7315.
30. Hill, C.P., Worthylake, D., Bancroft, D.P., Christensen, A.M. and Sundquist, W.I. (1996) Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc. Natl Acad. Sci. USA, 93, 3099-3104.
31. Hinshaw, J.E., Carragher, B.O. and Milligan, R.A. (1992) Architecture and design of the nuclear pore complex. Cell, 69, 1133-1141.
32. Hwang, S.S., Boyle, T.J., Lyerly, H.K. and Cullen, B.R. (1991) Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science, 253, 71-74.
33. Izaurralde, E. and Mattaj, I.W. (1992) Transport of RNA between nucleus and cytoplasm. Semin. Cell Biol., 3, 279-288.
34. Kalderon, D., Richardson, W.D., Markham, A.F. and Smith, A.E. (1984) Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature, 311, 33-38.
35. Katz, R.A. and Skalka, A.M. (1994) The retroviral enzymes. Annu. Rev. Biochem., 63, 133-173.
36. Koenig, S. et al. (1986) Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science, 233, 1089-1093.
37. LaCasse, E.C. and Lefebvre, Y.A. (1995) Nuclear localization signals overlap DNA-or RNA-binding domains in nucleic acid-binding proteins. Nucleic Acids Res., 23, 1647-1656.
38. Lewis, P.F. and Emerman, M. (1994) Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J. Virol., 68, 510-516.
39. Lewis, P., Hensel, M. and Emerman, M. (1992) Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J., 11, 3053-3058.
40. Li, Y., Hui, H., Burgess, C.J., Price, R.W., Sharp, P.M., Hahn, B.H. and Shaw, G.M. (1992) Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J. Virol., 66, 6587-6600.
41. Meyer, B.E. and Malim, M.H. (1994) The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev., 8, 1538-1547.
42. Meyer, B.E., Meinkoth, J.L. and Malim, M.H. (1996) Nuclear transport of the human immunodeficiency virus type 1, Visna virus, and equine infectious anemia virus Rev proteins: identification of a family of transferable nuclear export signals. J. Virol., 70, 2350-2359.
43. Michael, W.M., Choi, M. and Dreyfuss, G. (1995) A nuclear export signal in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein export pathway. Cell, 83, 415-422.
44. O'Brien, W.A. and Pomerantz, R.J. (1996) HIV infection and associated diseases. In Nathanson, N., Ahmed, R., Gonzalez-Scarano, F., Griffin, D.E., Holmes, K.V., Murphy, F.A. and Robinson, H.L. (eds), Viral Pathogenesis. Lippincott-Raven, Philadelphia, pp. 815-836.
45. Pettit, S.C. Moody, M.D., Wehbie, R.S., Kaplan, A.H., Nantermet, P.V., Klein, C.A. and Swanstrom, R. (1994) The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol., 68, 8017-8027.
46. Roe, T., Reynolds, T.C., Yu, G. and Brown, P.O. (1993) Integration of murine leukemia virus DNA depends on mitosis. EMBO J., 12, 2099-2108.
47. Rose, J.K. and Bergmann, J.E. (1983) Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein. Cell. 34, 513-524.
48. Schuitemaker, H. et al. (1992) Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol., 66, 356-363.
49. Shaw, G.M., Hahn, B.H., Arya, S.K., Groopman, J.E., Gallo, R.C. and Wong-Staal, F. (1984) Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. Science, 226, 1165-1171.
50. Simon, J.H.M. and Malim, M.H. (1996) The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J. Virol., 70, 5297-5305.
51. Simon, J.H.M., Southerling, T.E., Peterson, J.C., Meyer, B.E. and Malim, M.H. (1995) Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J. Virol., 69, 4166-4172.
52. Siomi, H. and Dreyfuss, G. (1995) A nuclear localization domain in the hnRNP Al protein. J. Cell Biol., 129, 551-560.
53. Soneoka, Y., Cannon, P.M., Ramsdale, E.E., Griffiths, J.C., Romano, G., Kingsman, S.M. and Kingsman, A.J. (1995) A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res., 23, 628-633.
54. Spearman, P., Wang, J.-J., Heyden, N.V. and Ratner, L. (1994) Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J. Virol., 68, 3232-3242.
55. van't Wout, A.B. et al. (1994) Macrophage-tropic variants initiate human immunodeficiency virus infection after sexual, parenteral, and vertical transmission. J. Clin. Invest., 94, 2060-2067.
56. von Schwedler, U., Kombluth, R.S. and Trono, D. (1994) The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc. Natl Acad. Sci. USA, 91, 6992-6996.
57. Wang, C.-T. and Barklis, E. (1993) Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J. Virol., 67, 4264-4273.
58. Weinberg, J.B., Matthews, T.J., Cullen, B.R. and Malim, M.H. (1991) Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J. Exp. Med., 174, 1477-1482.
59. Wiley, C.A., Schrier, R.D., Nelson, J.A., Lampert, P.W. and Oldstone, M.B.A. (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl Acad. Sci. USA, 83, 7089-7093.
60. Zho, T., Mo, H., Wang, N., Nam, D.S., Cao, Y., Koup, R.A. and Ho, D.D. (1993) Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science, 261, 1179-1181.
61. Zhou, W., Parent, L.J., Wills, J.W. and Resh, M.D. (1994) Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol., 68, 2556-2569.